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maries [PCS and MCS], the physical functioning domain [PF]).
To demonstrate responsiveness, mean changes in WPS-RA at
wk24 were compared between ACR20 responders and non-
responders. The Standardized Response of the Mean (SRM) was
used to quantify responsiveness. Comparisons were conducted
using a non-parametric bootstrap t-method. RESULTS: Subjects
with lower physical function/HRQoL scores had statistically
greater RA-associated productivity losses compared to subjects
with higher scores (25/32 evaluations statistically signiﬁcant).
HAQ-DI and SF-36 PF thresholds lead to statistically signiﬁcant
differences between groups in 7/8 WPS-RA questions. The PCS
showed differences in 6/8 questions; the MCS in 5/8. The smallest
differences related to absenteeism and days with outside help. At
wk24, ACR20 responders reported large gains in productivity,
whereas the ACR20 non-responders reported mainly worsening
(difference p-value  0.05). The effect size for changes in pro-
ductivity in responders was moderate to large for 6/8 items
(0.49–1.10). The effect size was small for absenteeism and days
with outside help (SRM = 0.4 and 0.24 respectively). In compari-
son, in non-responders, the magnitude of change was negligible
(SRM < 0.1) or small (SRM < 0.3). CONCLUSIONS: The
WPS-RA is valid and responsive as measure of work and house-
hold productivity in subjects with active RA.
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OBJECTIVES: To establish pertinent levels of FMQ (Fibromyal-
gia Moldofsky Questionnaire) score to guide a subject’s further
treatment, METHODS: The FMQ questionnaire, was adminis-
trated to a representative community sample of 1500 subjects in
UK along with two validated questionnaires (LFESSQ London
Fibromyalgia Epidemiology Study Screening Questionnaire and
CES-D Center for Epidemiologic Studies Depression Scale) and a
questionnaire assessing a decline in the restorative effects of sleep
(SQA Sleep Quality Assessment). A descriptive analysis of the
score was carried out using socio-demographic data (gender, age,
type of town and socio-professional class) and the complaints
reported by the subjects interviewed, RESULTS: The FMQ score
was higher among women and those over 50 (5.0; 5.3). Women
aged over 50 had an even higher FMQ score (5.5), which agreed
with existing epidemiological data on ﬁbromyalgia. There was
no relationship between the FMQ score and geographic location,
income, profession and sick leave prescribed by a doctor (regard-
less of length). The FMQ score was 3.0 in subjects who did not
state any pain and 4.1 in those who did not respond positively on
the LFESSQ. It increased to 8.7 among those who screened
positive on the LFESSQ. The FMQ score varied between 9.7 and
10.4 in subjects who responded positively on the LFESSQ and
who also experienced depressive symptoms, fatigue or a decline
in the restorative effects of sleep. The FMQ score was 10.7 for
subjects who screened positive on the LFESSQ and who also
experienced fatigue and depressive symptoms, and increased to
11.3 when the four symptoms were experienced at once, CON-
CLUSIONS: A FMQ score of less than 3 excludes a presumptive
diagnosis of ﬁbromyalgia syndrome and an FMQ score of above
8 should lead to specialist investigations.
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OBJECTIVES: To validate the SQA (Sleep Quality Assessment)
questionnaire which will help to identify subjects who with
an unrestorative sleep, METHODS: The SQA questionnaire,
was administered to a representative sample of 1500 subjects
from the general UK population along with three questionnaires
(FMQ: Fibromyalgia Moldofsky Questionnaire, LFESSQ
London Fibromyalgia Epidemiology Study Screening Question-
naire, and CES-D Center for Epidemiologic Studies Depression
Scale). The maximum score of 30 showed a large decline in the
restorative effect of sleep. Internal consistency, structural and
clinical validity were tested, RESULTS: Internal consistency was
highly satisfactory (aCronbach > 0.8). The items making up each
dimension were highly relevant to the dimension that they
covered (R > 0.4) and no item presented a signiﬁcant correlation
(>0.8) with another item. Subjects responding positively on the
LFESSQ had an SQA score that was signiﬁcantly higher than
subjects who responded negatively (14.6 vs 8.7). Similar differ-
ences were observed between subjects with and without probable
depressive symptoms (15.4 vs 8.4) and a strong presumption of
ﬁbromyalgia syndrome (16.9 vs 8.0). The SQA score was 7.0 in
subjects who did not report any pain and 7.1 in those who did
not respond positively on the LFESSQ. It increased to 14.7
among those who screened positive on the LFESSQ. The CES-D
score increased signiﬁcantly with the SQA score. The SQA score
was 16.7 [13.9–17.4] among subjects who screened positive on
the LFESSQ and who either experienced fatigue or depressive
symptoms or both, CONCLUSIONS: The restorative effect of
sleep is reduced when the SQA score is greater or equal to 14 and
good when the SQA score is less than 7. An SQA score of
between 7 and 14 necessitates further examinations, which may
include investigating physiological function during sleep.
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OBJECTIVES: To explore functional impact, limitation of daily
activities, burden and handicap related to FM in order to deﬁne
the burden on patients’ daily lives. To gather and organise this
material to develop a new Patient-Reported Outcomes (PRO)
questionnaire simultaneously in four European languages assess-
ing FM burden on patients’ daily lives. METHODS: PRO
questionnaire development follows a rigorous protocol and
methodology to ensure its reliability. An international committee
of three ﬁbromyalgia experts was set up and included in the
whole process. A literature review was conducted using burden-
and FM-related keywords. Concepts identiﬁed were organised
into a model. Exploratory interviews were performed with a
total of 15 patients in France, Germany and Spain. They were
recorded, transcribed word-for-word and systematically analysed
using a speciﬁcally developed coding grid. Concepts were orga-
nised into a separate model. Conﬁrmatory interviews were
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